Article Details

Market gears up for biosimilar boom in 2023 as Humira exclusivity draws to a close

Retrieved on: 2021-06-18 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

Market gears up for biosimilar boom in 2023 as Humira exclusivity draws to a close. View article details on hiswai:

Excerpt

Rather than fight the release of biosimilars indefinitely through new patents for old drugs — a strategy that saw AbbVie apply for more than 250 U.S. ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo